Detalhe da pesquisa
1.
BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment.
Int J Mol Sci
; 20(2)2019 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-30669483
2.
p53 modeling as a route to mesothelioma patients stratification and novel therapeutic identification.
J Transl Med
; 16(1): 282, 2018 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30316293
3.
Protocol for open-label randomized clinical trial of intensive surveillance versus standard postoperative follow-up in patients undergoing surgical resection for oesophageal and gastric cancer.
Br J Surg
; 110(10): 1359-1360, 2023 09 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37376769
4.
Minimal clinically important differences in patient reported outcomes after coronary artery bypass surgery in the arterial revascularization trial.
Eur J Cardiothorac Surg
; 2024 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38845077
5.
Aspirin Rescues Wnt-Driven Stem-like Phenotype in Human Intestinal Organoids and Increases the Wnt Antagonist Dickkopf-1.
Cell Mol Gastroenterol Hepatol
; 11(2): 465-489, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32971322
6.
What can independent research for mesothelioma achieve to treat this orphan disease?
Expert Opin Investig Drugs
; 28(8): 719-732, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31262194
7.
Sirtuin Family Members Selectively Regulate Autophagy in Osteosarcoma and Mesothelioma Cells in Response to Cellular Stress.
Front Oncol
; 9: 949, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31608237
8.
Anti-CTLA-4 therapy for malignant mesothelioma.
Immunotherapy
; 9(3): 273-280, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28231719
9.
Immunotherapy advances for mesothelioma treatment.
Expert Rev Anticancer Ther
; 17(9): 799-814, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28724330
10.
Promising investigational drug candidates in phase I and phase II clinical trials for mesothelioma.
Expert Opin Investig Drugs
; 26(8): 933-944, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28679291
11.
Myelodysplastic syndromes: advantages of a combined cytogenetic and molecular diagnostic workup.
Oncotarget
; 8(45): 79188-79200, 2017 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29108298
12.
Inhibition of the platelet-derived growth factor receptor beta (PDGFRB) using gene silencing, crenolanib besylate, or imatinib mesylate hampers the malignant phenotype of mesothelioma cell lines.
Genes Cancer
; 8(1-2): 438-452, 2017 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-28435517
13.
Tremelimumab for the treatment of malignant mesothelioma.
Expert Opin Biol Ther
; 15(12): 1819-29, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26560442